Glucosephosphate Dehydrogenase Deficiency
"Glucosephosphate Dehydrogenase Deficiency" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.
Descriptor ID |
D005955
|
MeSH Number(s) |
C15.378.071.141.150.480 C16.320.070.480 C16.320.565.202.402 C18.452.648.202.402
|
Concept/Terms |
Glucosephosphate Dehydrogenase Deficiency- Glucosephosphate Dehydrogenase Deficiency
- Deficiencies, Glucosephosphate Dehydrogenase
- Dehydrogenase Deficiencies, Glucosephosphate
- Dehydrogenase Deficiency, Glucosephosphate
- Deficiency, GPD
- Deficiencies, GPD
- GPD Deficiencies
- G6PD Deficiency
- Deficiencies, G6PD
- Deficiency, G6PD
- G6PD Deficiencies
- Glucose 6 Phosphate Dehydrogenase Deficiency
- Glucosephosphate Dehydrogenase Deficiencies
- GPD Deficiency
- Hemolytic Anemia Due to G6PD Deficiency
- Deficiency of Glucose-6-Phosphate Dehydrogenase
- Deficiency of Glucose 6 Phosphate Dehydrogenase
- Deficiency, Glucosephosphate Dehydrogenase
- Glucose-6-Phosphate Dehydrogenase Deficiency
- Deficiencies, Glucose-6-Phosphate Dehydrogenase
- Deficiency, Glucose-6-Phosphate Dehydrogenase
- Dehydrogenase Deficiencies, Glucose-6-Phosphate
- Dehydrogenase Deficiency, Glucose-6-Phosphate
- Glucose-6-Phosphate Dehydrogenase Deficiencies
|
Below are MeSH descriptors whose meaning is more general than "Glucosephosphate Dehydrogenase Deficiency".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Glucosephosphate Dehydrogenase Deficiency [C15.378.071.141.150.480]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Glucosephosphate Dehydrogenase Deficiency [C16.320.070.480]
- Metabolism, Inborn Errors [C16.320.565]
- Carbohydrate Metabolism, Inborn Errors [C16.320.565.202]
- Glucosephosphate Dehydrogenase Deficiency [C16.320.565.202.402]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Metabolism, Inborn Errors [C18.452.648]
- Carbohydrate Metabolism, Inborn Errors [C18.452.648.202]
- Glucosephosphate Dehydrogenase Deficiency [C18.452.648.202.402]
Below are MeSH descriptors whose meaning is more specific than "Glucosephosphate Dehydrogenase Deficiency".
- Glucosephosphate Dehydrogenase Deficiency
- Favism
This graph shows the total number of publications written about "Glucosephosphate Dehydrogenase Deficiency" by people in this website by year, and whether "Glucosephosphate Dehydrogenase Deficiency" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2017 | 11 | 2 | 13 |
2018 | 8 | 0 | 8 |
2019 | 5 | 2 | 7 |
2020 | 5 | 1 | 6 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Glucosephosphate Dehydrogenase Deficiency" by people in Profiles.
-
G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19. Pharmacogenomics J. 2021 12; 21(6):649-656.
-
Management of children with glucose-6-phosphate dehydrogenase deficiency presenting with acute haemolytic crisis during the SARs-COV-2 pandemic. Vox Sang. 2022 Jan; 117(1):80-86.
-
COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients. Nucleosides Nucleotides Nucleic Acids. 2021; 40(5):505-517.
-
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review. Mol Biol Rep. 2021 Mar; 48(3):2973-2978.
-
Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach. Molecules. 2021 02 23; 26(4).
-
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg? Ann Hematol. 2021 Mar; 100(3):667-673.
-
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19). Free Radic Res. 2021 Apr; 55(4):364-374.
-
Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine? J Pediatr Hematol Oncol. 2021 01; 43(1):35-36.
-
COVID-19 and hydroxychloroquine side-effects: glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia. QJM. 2020 12 01; 113(12):890-891.
-
Evaluation of glucose-6-phosphate dehydrogenase (G6PD) status in US military and VA patients with COVID-19 infection. BMJ Mil Health. 2021 Apr; 167(2):144.